AGBK EBITDA
R$1.01BTTM · BRL
Period ending:
AGBK FY EBITDABRL
R$1.54BR$0.00
2022-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in BRL. Dates are period ends; a fiscal year may differ from a calendar year.
AGBK ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 4 observations from Dec 31, 2022 to Dec 31, 2025.
| Period ending | EBITDA (BRL) |
|---|---|
| 1,538,689,000 | |
| 1,205,853,000 | |
| 716,493,000 | |
| 364,086,000 |
Compare ebitda
Other companies in —. Each page shows its own reporting periods and currency.
- Taiwan Semiconductor Manufacturing Company Ltd. (TSM) ebitda
- HSBC Holdings, plc. Common Stock (HSBC) ebitda
- Shell PLC American Depositary Shares (each representing two (2) Ordinary Shares) (SHEL) ebitda
- Novartis AG Common Stock (NVS) ebitda
- Royal Bank Of Canada Common Stock (RY) ebitda
- Alibaba Group Holding Limited American Depositary Shares each representing eight Ordinary share (BABA) ebitda
- SAP SE ADS (SAP) ebitda
- AstraZeneca PLC Ordinary Shares (AZN) ebitda
All AGBK financial metrics · AGBK stock overview · How to interpret financial metrics
